Meridian Bioscience

$17.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.85 (-4.58%) As of 6:26 PM UTC today

Why Robinhood?

You can buy or sell VIVO and other stocks, options, and ETFs commission-free!

About VIVO

Meridian Bioscience, Inc. engages in the development, manufacture, sale, and distribution of diagnostic test kits, antigens, reagents, and related products. It operates through the following segments: Diagnostics and Life Science. The Diagnostics segment consists testing platforms and technologies such as Isothermal DNA Amplification, Rapid Immunoassay, Enzyme-linked Immunoassay, and Anodic Stripping Voltammetry. The Life Science segment distributes bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH. The listed name for VIVO is Meridian Bioscience Inc. Common Stock.

CEO
John Patrick Kenny
Employees
750
Headquarters
Cincinnati, Ohio
Founded
1976
Market Cap
760.08M
Price-Earnings Ratio
17.76
Dividend Yield
Average Volume
509.10K
High Today
$18.69
Low Today
$17.63
Open Price
$18.69
Volume
253.39K
52 Week High
$26.58
52 Week Low
$5.51

Collections

VIVO Earnings

$0.00
$0.18
$0.37
$0.55
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Actual
Expected Feb 5, Pre-Market

You May Also Like